medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2024, Número 2

<< Anterior Siguiente >>

Acta Pediatr Mex 2024; 45 (2)


Obesidad. Un problema de salud que requiere una interpretación y solución multisectorial

Perea MA, Ríos GPT, Lara CAG, Padrón MMM, González VAL, Pecero HMJ, Suárez NP, Sánchez GJA, Santiago LLM, Perea CAL, Reyes GU, Estrada JAJ, Zamora EAM

Idioma: Español
Referencias bibliográficas: 39
Paginas: 161-184
Archivo PDF: 406.07 Kb.


RESUMEN

La obesidad constituye un desafío de salud global que demanda una estrategia multisectorial para su atención. Se origina por interacciones genéticas, ambientales y conductuales. Los factores socioeconómicos y culturales influyen en su prevalencia y en las consecuencias asociadas. Su prevención y tratamiento efectivos requieren enfoques que integren un estilo de vida, un ambiente y un perfil de políticas públicas específicos. La colaboración entre los sectores de la salud, educación, deporte, economía y la políticas es esencial. Un entendimiento holístico y acciones coordinadas son cruciales para mitigar esta epidemia y mejorar la salud poblacional.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gobierno de México. Estrategia Nacional para la Prevencióny el Control del sobrepeso, la obesidad y la diabetes 2013 [Internet]. Ciudad de México: Secretaría de Salud;2013 [citado el día/mes/año]. Disponible en:http://www.cenaprece.salud.gob.mx/descargas/pdf/EstrategiaNacionalSobrepeso.pdf

  2. Ghoch M, Fakhoury R. Challenges and new directions inobesity management: lifestyle modification programmes,pharmacotherapy and bariatric surgery. J Popul Ther ClinPharmacol. 2019 May 23;26(2):e1-e4. doi: 10.15586/jptcp.v26i2.599. PMID: 31577079.

  3. Steenblock C, Hassanein M, Khan EG, Yaman M, KamelM, Barbir M, Lorke DE, Everett D, Bejtullah S, Lohmann T,Lindner U, Tahirukaj E, Jirjees FJ, Soliman SSM, Quitter F,Bornstein SR. Obesity

  4. COVID-19: What are the Consequences? Horm Metab Res.2022 Aug;54(8):496-502. doi: 10.1055/a-1878-9757. Epub2022 Jun 20. PMID: 35724688; PMCID: PMC9427204.

  5. Tiwari A, Balasundaram P. Public Health ConsiderationsRegarding Obesity. [Updated 2023 Jun 5]. In: StatPearls[Internet]. Treasure Island (FL): StatPearls Publishing;2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572122/

  6. Graber E. Childhood Obesity Prevention Strategies MustStart Early. Amer Soc Nutr 2020. Disponible en: https://nutrition.org/childhood-obesity-prevention-strategiesmust-start-early/

  7. Shamah-Levy T, Gaona-Pineda EB, Cuevas-Nasu L, Morales-Ruan C, Valenzuela-Bravo DG, Méndez-Gómez HumaránI, Ávila-Arcos MA. Prevalencias de sobrepeso y obesidaden población escolar y adolescente de México. EnsanutContinua 2020-2022. Salud Publica Mex. 2023;65(supl1):S218-S224. https://doi.org/10.21149/14762

  8. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs103 and 107 regulate insulin sensitivity. Nature. 2011Jun;474(7353):649-653. doi: 10.1038/nature10112. PMID:21654750.

  9. Lam BCC, Lim AYL, Chan SL, Yum MPS, Koh NSY, FinkelsteinEA. The impact of obesity: a narrative review. Singapore MedJ. 2023 Mar;64(3):163-171. doi: 10.4103/singaporemedj.SMJ-2022-232. PMID: 36876622; PMCID: PMC10071857.

  10. Hsu CN, Hou CY, Hsu WH, Tain YL. Early-Life Origins ofMetabolic Syndrome: Mechanisms and Preventive Aspects.Int J Mol Sci. 2021 Nov 2;22(21):11872. doi: 10.3390/ijms222111872. PMID: 34769303; PMCID: PMC8584419.

  11. Ling C, Rönn T. Epigenetics in Human Obesity and Type 2Diabetes. Cell Metab. 2019 May 7;29(5):1028-1044. doi:10.1016/j.cmet.2019.03.009. Epub 2019 Apr 11. PMID:30982733; PMCID: PMC6509280

  12. Roblin L. Childhood obesity: food, nutrient, and eatinghabittrends and influences. Appl Physiol Nutr Metab.2007 Aug;32(4):635-645. doi: 10.1139/H07-046. PMID:17622277.

  13. Tiffon C. The Impact of Nutrition and Environmental Epigeneticson Human Health and Disease. Int J Mol Sci. 2018Nov 1;19(11):3425. doi: 10.3390/ijms19113425. PMID:30388784; PMCID: PMC6275017.

  14. World Health Organization. Physical inactivity: a leadingcause of disease and disability, warns WHO. [Internet].Geneva: World Health Organization; 2002 Apr 4 [cited2024 Mar 16]. Available from: https://www.who.int/news/item/04-04-2002-physical-inactivity-a-leading-cause-ofdisease-and-disability-warns-who

  15. Okunogbe A, Nugent R, Spencer G, et al Economic impactsof overweight and obesity: current and future estimatesfor eight countries. BMJ Global Health 2021;6:e006351.

  16. Gjermeni E, Kirstein AS, Kolbig F, Kirchhof M, BundalianL, Katzmann JL, Laufs U, Blüher M, Garten A, Le Duc D.Obesity - An Update on the Basic Pathophysiology andReview of Recent Therapeutic Advances. Biomolecules.2021 Sep 29;11(10):1426. doi: 10.3390/biom11101426.PMID: 34680059; PMCID: PMC8533625.

  17. Reilly S, Saltiel A. Adapting to obesity with adipose tissueinflammation. Nat Rev Endocrinol. 2017;13:633-643. doi:10.1038/nrendo.2017.90

  18. Manna P, Jain SK. Obesity, oxidative stress, adipose tissuedysfunction, and the associated health risks: causes andtherapeutic strategies. Metab Syndr Relat Disord. 2015Dec;13(10):423-444. doi: 10.1089/met.2015.0095. PMID:26569333; PMCID: PMC4808277.

  19. Nunan E, Wright CL, Semola OA, Subramanian M, BalasubramanianP, Lovern PC, Fancher IS, Butcher JT. Obesity asa premature aging phenotype - implications for sarcopenicobesity. Geroscience. 2022 Jun;44(3):1393-1405. doi:10.1007/s11357-022-00567-7. Epub 2022 Apr 26. PMID:35471692; PMCID: PMC9213608.

  20. Perea-Martínez A, López-Navarrete GE, Padrón-MartínezM, Lara-Campos AG, Santamaría-Arza C, Ynga-DurandMA, et al. Evaluación, diagnóstico, tratamiento y oportunidadesde prevención de la obesidad. Acta Pediat Mex.2014;35:316-337.

  21. Torres Tamayo M, Aguilar Herrera BE, Altamirano BustamanteN, et al. Consenso de expertos sobre prevención, diagnósticoy tratamiento de la obesidad en edad pediátrica.Bol Med Hosp Infant Mex. 2015;72(Suppl 1):1-28.

  22. Moreno González MI. Circunferencia de cintura: unamedición importante y útil del riesgo cardiometabólico. RevChil Cardiol. 2010;29:85-87. http://dx.doi.org/10.4067/S0718-85602010000100008

  23. Padrón-Martínez MM, Perea-Martínez A, López-NavarreteGE. Relación cintura/estatura, una herramienta útil paradetectar riesgos cardiovascular y metabólico en niños. ActaPediatr Mex. 2016;37(5):297-301.

  24. Prochaska JO, Velicer WF. The transtheoretical model ofhealth behavior change. Am J Health Promot. 1997 Sep-Oct;12(1):38-48. doi: 10.4278/0890-1171-12.1.38. PMID:10170434.

  25. de Freitas PP, de Menezes MC, Dos Santos LC, Pimenta AM,Ferreira AVM, Lopes ACS. The transtheoretical model is aneffective weight management intervention: a randomizedcontrolled trial. BMC Public Health. 2020 May 11;20(1):652.doi: 10.1186/s12889-020-08796-1. PMID: 32393214;PMCID: PMC7216547.

  26. Mastellos N, Gunn LH, Felix LM, Car J, Majeed A. Transtheoreticalmodel stages of change for dietary and physicalexercise modification in weight loss management for overweightand obese adults. Cochrane Database of SystematicReviews. 2014;(2):CD008066. DOI: 10.1002/14651858.CD008066.pub3.

  27. Johnson SS, Paiva AL, Cummins CO, Johnson JL, DymentSJ, Wright JA, Prochaska JO, Prochaska JM, Sherman K.Transtheoretical model-based multiple behavior interventionfor weight management: effectiveness on a populationbasis. Prev Med. 2008 Mar;46(3):238-46. doi: 10.1016/j.ypmed.2007.09.010. Epub 2007 Oct 23. PMID: 18055007;PMCID: PMC2327253.

  28. Yoo H, Suneja U. Pediatric Obesity Nutritional Guidelines.[Updated 2023 May 1]. In: StatPearls [Internet]. TreasureIsland (FL): StatPearls Publishing; 2024 Jan-. Availablefrom: https://www.ncbi.nlm.nih.gov/books/NBK560926/

  29. Rozga M, Handu D. Nutrition interventions for pediatricobesity prevention: An umbrella review of systematic reviews.Nutrients. 2023;15:5097. https://doi.org/10.3390/nu15245097

  30. Fornari E, Brusati M, Maffeis C. Nutritional strategies forchildhood obesity prevention. Life. 2021;11:532. https://doi.org/10.3390/life11060532

  31. Kim J, Lim H. Nutritional management in childhood obesity.J Obes Metab Syndr. 2019 Dec;28(4):225-235. doi: 10.7570/jomes.2019.28.4.225. Epub 2019 Dec 30. PMID: 31909365;PMCID: PMC6939706.

  32. Singhal V, Sella AC, Malhotra S. Pharmacotherapy inpediatric obesity: current evidence and landscape. CurrOpin Endocrinol Diabetes Obes. 2021 Feb 1;28(1):55-63.doi: 10.1097/MED.0000000000000587. PMID: 33186194;PMCID: PMC8082722.

  33. Herouvi D, Paltoglou G, Soldatou A, Kalpia C, Karanasios S,Karavanaki K. Lifestyle and pharmacological interventionsand treatment indications for the management of obesityin children and adolescents. Children. 2023;10:1230.https://doi.org/10.3390/children10071230

  34. Commonwealth of Australia. The National Obesity Strategy2022-2032. Health Ministers Meeting; 2022.

  35. Esdaile EK, Rissel C, Baur LA, Wen LM, Gillespie J. Intergovernmentalpolicy opportunities for childhood obesityprevention in Australia: Perspectives from senior officials.PLoS ONE. 2022;17(4):e0267701. https://doi.org/10.1371/journal.pone.0267701

  36. Obesity Action Coalition. Obesity Action Coalition’s policyplatform: beliefs and efforts supported by the OAC.

  37. World Health Organization. Application of the essentialpublic health functions: an integrated and comprehensiveapproach to public health. 2024. Disponible en: https://www.who.int/publications/i/item/9789240088306

  38. World Health Organization. Application of the essentialpublic health functions: an integrated andcomprehensive approach to public health. 2024.Disponible en: https://iris.who.int/bitstream/handle/10665/375864/9789240088306-eng.pdf?sequence=1

  39. Commission on Ending Childhood Obesity. Report of theCommission on Ending Childhood Obesity. World HealthOrganization, Geneva; 2016. Disponible en: http://www.who.int/end-childhood-obesity/en/ (accedido el 25 deenero de 2016).




2020     |     www.medigraphic.com